McGuire Investment Group LLC Raises Position in Catalent, Inc. (NYSE:CTLT)



McGuire Investment Group LLC grew its position in Catalent, Inc. (NYSE:CTLT – Get Rating) by 0.3% during the 1st quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor owned 123,715 shares of the company’s stock after acquiring an additional 351 during the period. Catalent comprises 2.5% of McGuire Investment Group LLC’s portfolio, making the stock its 13th largest holding. McGuire Investment Group LLC’s holdings in Catalent were worth $13,720,000 at the end of the most recent quarter.

Several other large investors have also recently modified their holdings of CTLT. Leonard Green & Partners LP acquired a new stake in shares of Catalent in the fourth quarter valued at about $616,791,000. Norges Bank purchased a new stake in shares of Catalent during the fourth quarter worth about $195,690,000. Veritas Asset Management LLP grew its holdings in shares of Catalent by 29.2% during the fourth quarter. Veritas Asset Management LLP now owns 6,070,286 shares of the company’s stock worth $777,179,000 after buying an additional 1,372,841 shares in the last quarter. TD Asset Management Inc. grew its holdings in shares of Catalent by 84.5% during the fourth quarter. TD Asset Management Inc. Now owns 1,413,444 shares of the company’s stock worth $180,963,000 after buying an additional 647,484 shares in the last quarter. Finally, BlackRock Inc. grew its holdings in shares of Catalent by 4.4% during the fourth quarter. BlackRock Inc. Now owns 14,998,086 shares of the company’s stock worth $1,920,204,000 after buying an additional 627,853 shares in the last quarter. 98.05% of the stock is currently owned by institutional investors and hedge funds.

Several equities research analysts have issued reports on the stock. StockNews.com assumed coverage on shares of Catalent in a research note on Thursday, March 31st. They set a “hold” rating for the company. Deutsche Bank Aktiengesellschaft decreased their objective price on shares of Catalent from $129.00 to $110.00 and set a “hold” rating for the company in a research note on Tuesday, April 12th. Two research analysts have rated the stock with a hold rating and six have assigned a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Moderate Buy” and an average target price of $142.86.

CTLT opened at $105.99 on Wednesday. The stock has a market capitalization of $18.99 billion, a PE ratio of 38.40, a P/E/G ratio of 1.55 and a beta of 1.32. The firm’s fifty day moving average price is $102.31 and its 200 day moving average price is $104.78. The company has a debt-to-equity ratio of 0.90, a current ratio of 2.89 and a quick ratio of 2.25. Catalent, Inc. has a 12-month low of $86.34 and a 12-month high of $142.64.

Catalent (NYSE:CTLT – Get Rating) last posted its quarterly earnings results on Tuesday, May 3rd. The company reported $1.00 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.89 by $0.11. The firm had revenue of $1.27 billion for the quarter, compared to analysts’ expectations of $1.22 billion. Catalent had a net margin of 10.72% and a return on equity of 15.07%. The firm’s quarterly revenue was up 20.9% on a year-over-year basis. During the same period in the prior year, the company posted $0.78 earnings per share. On average, equities research analysts forecast that Catalent, Inc. will post 3.57 earnings per share for the current fiscal year.

About Catalent (Get Rating)

Catalent, Inc, together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. It operates through four segments: Biologics, Softgel and Oral Technologies, Oral and Specialty Delivery, and Clinical Supply Services.

Further Reading

Want to see what other hedge funds are holding CTLT? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Catalent, Inc. (NYSE:CTLT – Get Rating).

Institutional Ownership by Quarter for Catalent (NYSE:CTLT)



Receive News & Ratings for Catalent Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for Catalent and related companies with MarketBeat.com’s FREE daily email newsletter.

.

Leave a Comment